Table IV.
Condensed summary of associations between demographic, comorbidity, and anatomic characteristics and postoperative complications in each classification system
| Institutional | VQI | NSQIP | PSI | |
|---|---|---|---|---|
| Any complication | ||||
| Nonwhite race | 10 (.37) | 11 (.23) | 8 (<.01) | 3 (.69) |
| CHF | 6 (.27) | 8 (.65) | 7 (.08) | 5 (<.01) |
| ≥Suprarenal clamp | 35 (.29) | 63 (<.01) | 33 (.78) | 13 (.15) |
| ≥Supramesenteric clamp | 26 (.01) | 45 (<.01) | 23 (.13) | 12 (<.01) |
| ≥6.5 cm | 17 (.26) | 28 (.17) | 18 (.13) | 8 (.02) |
| ≥Suprarenal extent | 11 (.06) | 20 (<.01) | 11 (.06) | 6 (<.01) |
| ≥Pararenal extent | 18 (.08) | 32 (<.01) | 16 (.32) | 9 (<.01) |
| Aortorenal bypass | 22 (.03) | 40 (<.01) | 20 (.15) | 8 (.10) |
| Hemorrhagic | ||||
| Age ≥75 years | 0 (.36) | 14 (.78) | 4 (.05) | 0 (.43) |
| HLD | 1 (.02) | 6 (.05) | 6 (.22) | 1 (.08) |
| CTD | 1 (.13) | 2 (.14) | 2 (.06) | 1 (.05) |
| Respiratory | ||||
| Nonwhite race | 7 (.06) | 6 (.03) | 5 (.53) | 2 (.63) |
| COPD | 11 (<.01) | 8 (.03) | 11 (.03) | 4 (.24) |
| CHF | 6 (<.01) | 6 (<.01) | 7 (<.01) | 3 (.01) |
| PVD | 6 (.13) | 6 (.02) | 7 (.09) | 3 (.18) |
| ≥Supramesenteric clamp | 14 (.02) | 10 (.06) | 15 (.02) | 7 (.02) |
| ≥6.5 cm | 11 (.03) | 8 (.07) | 12 (.01) | 5 (.06) |
| ≥Suprarenal extent | 5 (.32) | 4 (.27) | 4 (.27) | 3 (.14) |
| Cardiac | ||||
| CAD | 8 (.07) | 12 (.07) | 8 (.04) | – |
| >6.5 cm | 5 (.26) | 9 (.06) | 6 (.02) | – |
| Renal | ||||
| Male | 11 (086) | 43 (.03) | 8 (.53) | 2 (.37) |
| Nonwhite race | 6 (.02) | 8 (.62) | 4 (.04) | 2 (<.01) |
| Symptomatic | 7 (.07) | 15 (.67) | 5 (.04) | 1 (.37) |
| PVD | 5 (.06) | 9 (.80) | 4 (.05) | 1 (.21) |
| ≥Suprarenal clamp | 5 (.05) | 13 (.02) | 4 (.03) | 0 (.54) |
| ≥Supramesenteric clamp | 10 (.03) | 33 (<.01) | 7 (.05) | 2 (.09) |
| ≥Suprarenal extent | 5 (.05) | 13 (.02) | 4 (.03) | 0 (.54) |
| ≥Pararenal extent | 7 (.12) | 23 (<.01) | 6 (.03) | 0 (.36) |
| Aortorenal bypass | 8 (.12) | 28 (<.01) | 5 (.28) | 1 (.64) |
| ≥7.5 cm | 3 (.29) | 9 (.12) | 3 (.03) | 1 (.06) |
CAD, Coronary artery disease; CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease; CTD, connective tissue disease; HLD, hyperlipidemia; HTN, hypertension; NSQIP, National Surgical Quality Improvement Program; PSI, Patient Safety Indicator; PVD, peripheral vascular disease; VQI, Vascular Quality Initiative.
Results are described as frequencies (P value). Boldface P values represent statistical significance. Unlisted associations were nonsignificant.